SAN FRANCISCO, CA, UNITED STATES, January 13, 2026 /EINPresswire.com/ -- Bringing together public institutions, ...

European investment firm Gimv will no longer put funds into the life sciences sector, choosing instead to focus on its ...

Kos Biotechnology Partners ("Kos"), a global life sciences investment firm, today announced the closing of a financing round in Epikast, a premier provider of technology-enabled commercial and ...

For biotech companies the past two years have been challenging. Biotech investments have not reached the record levels of ...

AstraZeneca has outlined plans to invest $15 billion in China through 2030, making a broad commitment to the country to ...

The University of Pennsylvania, German biotech firm BioNTech, and Osage University Partners, a Bala Cynwyd venture capital ...

UK biotech showed resilience in a tough 2025 for healthcare funding, suggesting investor interest could grow in 2026.

A life sciences hub in Syracuse is getting a major upgrade as New York pushes to grow its biotechnology sector. Gov. Kathy ...

F. Hoffmann-La Roche, one of the world’s largest biotechnology companies, announced last week that it would more than triple ...

Inside the North Carolina Biotechnology Center on Wednesday, large crowds waited in line during a job fair to connect with local companies in the life sciences space. "I'll just go back to 1984, where ...